EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Cardio‐renal‐metabolic disease in primary care setting

Mahmoud Ibrahim iD, Ebtesam M Ba-Essa iD, Jason Baker iD, Avivit Cahn iD, Antonio Ceriello iD, Francesco Cosentino iD, Melanie J Davies iD, Robert H Eckel iD, Luc Van Gaal, Peter Gaede iD, Yehuda Handelsman iD, Samuel Klein iD and 11 more

Diabetes/Metabolism Research and Reviews · 2024

DOI: 10.1002/dmrr.3755 ↗

At a glance

Übersichtsarbeit in Diabetes/Metabolism Research and Reviews, 2024. Written by Mahmoud Ibrahim and 22 co-authors. Institution: EDC, Centre for Diabetes Education, Charlotte, North Carolina, USA. Major MEDLINE topics: Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 2 Inhibitors, Heart Diseases, Cardiovascular Diseases. Cited 13 times so far (Crossref); 188 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, NCATS NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

In the primary care setting providers have more tools available than ever before to impact positively obesity, diabetes, and their complications, such as renal and cardiac diseases. It is important to recognise what is available for treatment taking into account diabetes heterogeneity. For those who develop type 2 diabetes (T2DM), effective treatments are available that for the first time have shown a benefit in reducing mortality and macrovascular complications, in addition to the well‐established benefits of glucose control in reducing microvascular complications. Some of the newer medications for treating hyperglycaemia have also a positive impact in reducing heart failure (HF). Technological advances have also contributed to improving the quality of care in patients with diabetes. The use of technology, such as continuous glucose monitoring systems (CGM), has improved significantly glucose and glycated haemoglobin A1c (HbA1c) values, while limiting the frequency of hypoglycaemia. Other technological support derives from the use of predictive algorithms that need to be refined to help predict those subjects who are at great risk of developing the disease and/or its complications, or who may require care by other specialists. In this review we also provide recommendations for the optimal use of the new medications; sodium‐glucose co‐transporter‐2 inhibitors (SGLT2i) and Glucagon‐like peptide‐receptor agonists 1 (GLP1RA) in the primary care setting considering the relevance of these drugs for the management of T2DM also in its early stage.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsHeart DiseasesCardiovascular DiseasesHumansHypoglycemic AgentsBlood Glucose Self-MonitoringBlood GlucoseGlucagon-Like Peptide 1Primary Health CareGlucagon-Like Peptide-1 Receptor

Author keywords

CVOTschronic kidney diseaseheart failureobesitytechnologytype 2 diabetes

Substances

Hypoglycemic AgentsBlood GlucoseSodium-Glucose Transporter 2 InhibitorsGlucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor

Authors and institutions

  • EDC, Centre for Diabetes Education, Charlotte, North Carolina, USA.
  • Al-Rawdah General Hospital, Dammam, Saudi Arabia.
  • Weill Cornell Medicine, New York, New York, USA.
  • The Diabetes Unit & Endocrinology and Metabolism Unit, Hadassah Hebrew University Hospital, Jerusalem, Israel.
  • IRCCS MultiMedica, Milan, Italy.
  • Unit of Cardiology, Department of Medicine Solna, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.

ORCID profiles: Mahmoud Ibrahim, Ebtesam M Ba-Essa, Jason Baker, Avivit Cahn, Antonio Ceriello, Francesco Cosentino, Melanie J Davies, Robert H Eckel, Peter Gaede, Yehuda Handelsman, Samuel Klein, Richard David Leslie, Stefano Del Prato, Francesco Prattichizzo, Petar M Seferovic, Eberhard Standl, Abraham Thomas, Jaakko Tuomilehto, Paul Valensi, Guillermo E Umpierrez

Funding

  • NIDDK NIH HHS
  • NCATS NIH HHS

Cite

APA

Ibrahim, M., Ba-Essa, E. M., Baker, J., Cahn, A., Ceriello, A., Cosentino, F., Davies, M. J., Eckel, R. H., Van Gaal, L., Gaede, P., Handelsman, Y., Klein, S., Leslie, R. D., Pozzilli, P., Del Prato, S., Prattichizzo, F., Schnell, O., Seferovic, P. M., Standl, E., …, & Umpierrez, G. E. (2024). Cardio‐renal‐metabolic disease in primary care setting. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.3755

Vancouver

Ibrahim M, Ba-Essa EM, Baker J, Cahn A, Ceriello A, Cosentino F, et al. Cardio‐renal‐metabolic disease in primary care setting. Diabetes/Metabolism Research and Reviews. 2024. doi:10.1002/dmrr.3755

BibTeX
@article{Ibrahim2024,
  author = {Ibrahim, Mahmoud and Ba-Essa, Ebtesam M and Baker, Jason and Cahn, Avivit and Ceriello, Antonio and Cosentino, Francesco and Davies, Melanie J and Eckel, Robert H and Van Gaal, Luc and Gaede, Peter and Handelsman, Yehuda and Klein, Samuel and Leslie, Richard David and Pozzilli, Paolo and Del Prato, Stefano and Prattichizzo, Francesco and Schnell, Oliver and Seferovic, Petar M and Standl, Eberhard and Thomas, Abraham and Tuomilehto, Jaakko and Valensi, Paul and Umpierrez, Guillermo E},
  title = {Cardio‐renal‐metabolic disease in primary care setting},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2024},
  doi = {10.1002/dmrr.3755}
}
Start for free →